Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers

Not Applicable

Completed

Conditions: Gastric Cancer
Lung Cancer

Interventions: Procedure: respiration correlated CT scan

First Posted Date: 2010-10-01

Last Posted Date: 2018-02-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT01213004

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Phase 2

Completed

Conditions: Sarcoma
Liposarcoma

Interventions: Drug: Palbociclib 125mg
Drug: Palbociclib 200mg

First Posted Date: 2010-09-27

Last Posted Date: 2017-11-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 90

Registration Number: NCT01209598

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Radiation: multiple beams utilizing either intensity-modulated or 3D-conformal techniques

First Posted Date: 2010-09-16

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 110

Registration Number: NCT01203839

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Follow-up Only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk (Follow-up Only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen (Follow-up Only), Montvale, New Jersey, United States

and more 5 locations

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Phase 4

Completed

Conditions: Acute Myelogenous Leukemia
Myelodysplastic Syndrome

Interventions: Drug: posaconazole
Drug: micafungin

First Posted Date: 2010-09-13

Last Posted Date: 2018-05-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 113

Registration Number: NCT01200355

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins

Not Applicable

Completed

Conditions: Rectal Cancer

Interventions: Procedure: Eppendorf hypoximeter

First Posted Date: 2010-08-27

Last Posted Date: 2012-10-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT01189877

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib

Phase 2

Terminated

Conditions: Lung Cancer

Interventions: Drug: erlotinib

First Posted Date: 2010-08-26

Last Posted Date: 2015-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT01189435

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Early Phase 1

Active, not recruiting

Conditions: Sarcoma
Desmoplastic Small Round Cell Tumor (DSRCT)

Interventions: Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator

First Posted Date: 2010-08-26

Last Posted Date: 2023-09-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT01189643

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites

Not Applicable

Completed

Conditions: Ascites

Interventions: Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire

First Posted Date: 2010-08-25

Last Posted Date: 2020-02-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT01188746

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Phase 2

Terminated

Conditions: Colon Cancer
Rectal Cancer

Interventions: Drug: MK-2206

First Posted Date: 2010-08-23

Last Posted Date: 2015-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1

Registration Number: NCT01186705

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Progressive Stretching
Behavioral: Linear Aerobic Training
Behavioral: Nonlinear Aerobic Training
Other: Cardiopulmonary exercise test (CPET)
Other: Blood draws

First Posted Date: 2010-08-23

Last Posted Date: 2024-03-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 174

Registration Number: NCT01186367

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy